Vaxchora®
VAXCHORA is a vaccine indicated for active immunization against disease caused by Vibrio cholerae serogroup O1. VAXCHORA is approved for use in adults 18 through 64 years of age traveling to cholera-affected areas.
Availability: Commercially Available
| Manufacturer |
| Emergent BioSolutions, Inc. |
| Product Name |
| Vaxchora® |
| Detection Category |
| Biological |
| Detection Method |
| Medical Countermeasure |
| Application |
| Personal Protective Equipment; |
| Equipment Type |
| PPE |
| Product Synopsis |
| VAXCHORA is a vaccine indicated for active immunization against disease caused by Vibrio cholerae serogroup O1. VAXCHORA is approved for use in adults 18 through 64 years of age traveling to cholera-affected areas. |
| Availability |
| Commercially Available |
| Technology Readiness Level (TRL) |
| 9 |
| Market Entry Date |
| 2016 |
| User Feedback Sources |
| Indifferent/No user feedback |
| Supporting Documentation |
| Docs: Vaxchora Product Sheet.pdf; |
| Weight |
| <1 lb. |
| Power Requirements |
| None |
| Transportability |
| Pocket Size |
| Live Agent Tested |
| Vibrio cholerae serogroup O1 |
| Operating Time |
| Preventative administration prior to exposure |
| Standards Met |
| FDA |
| Training Required |
| <1 hour training |
| Training Available |
| Yes |
| Manuals Available |
| Yes |
